LLY and ADVM Related Headlines
Go Back- Abivax soars on report of Eli Lilly meeting French officials over possible deal
- Lilly completes Adverum acquisition for $3.56 per share plus CVRs
- Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
- Lilly to acquire Adverum Biotechnologies for up to $12.47 per share
- Lilly to Acquire Adverum Biotechnologies
LLY and ADVM Related Press Releases
Go Back- Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
- Lilly to Acquire Adverum Biotechnologies
